Design and evaluation of an economic taste-masked dispersible tablet of pyridostigmine bromide, a highly soluble drug with an extremely bitter taste

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 12, 2012, Pages 1514-1521

  Tan, Qunyou ^a   Zhang, Li ^b   Zhang, Liangke ^b   Teng, Yongzhen ^b   Zhang, Jingqing ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bioequivalence; Dispersible tablet; Inclusion complex; Pyridostigmine bromide; Taste masked

Indexed keywords

BETA CYCLODEXTRIN; PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ARTICLE; BITTER TASTE; COST; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; NONHUMAN; PHYSICAL CHEMISTRY; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; ULTRAVIOLET SPECTROSCOPY; WEIGHT;

BETA-CYCLODEXTRINS; DRUG DESIGN; FEMALE; HUMANS; MALE; MOLECULAR STRUCTURE; PYRIDOSTIGMINE BROMIDE; REFERENCE VALUES; SOLUBILITY; TABLETS; TASTE; TASTE PERCEPTION;

EID: 84871188805     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c12-00629     Document Type: Article

References (38)

1. Borrmann S., Sallas W. M., Machevo S., González R., Björkman A., Mårtensson A., Hamel M., Juma E., Peshu J., Ogutu B., Djimdé A., D'Alessandro U., Marrast A. C., Lefèvre G., Kern S. E., Trop. Med. Int. Health, 15, 434-441 (2010).
2. Fini A., Bergamante V., Ceschel G. C., Ronchi C., de Moraes C. A., Eur. J. Pharm. Biopharm., 69, 335-341 (2008).
3. Shi S., Liu Y., Wu J., Li Z., Zhao Y., Zhong D., Zeng F., Clin. Ther., 32, 1977-1986 (2010).
4. Ostrowski M., Wilkowska E., Baczek T., Drug Dev. Ind. Pharm., 35, 981-985 (2009).
5. Jamal G. A., Hansen S., Apartopoulos F., Peden A., J. Neurol. Neurosurg. Psychiatry, 60, 449-451 (1996).
6. Amourette C., Lamproglou I., Barbier L., Fauquette W., Zoppe A., Viret R., Diserbo M., Behav. Brain Res., 203, 207-214 (2009).
7. Kayitare E., Vervaet C., Mehuys E., Kayumba P. C., Ntawukulilyayo J. D., Karema C., Bortel V., Remon J. P., Int. J. Pharm., 392, 29-34 (2010).
8. Douroumis D., Expert Opin. Drug Deliv., 8, 665-675 (2011).
9. Kayumba P. C., Huyghebaert N., Cordella C., Ntawukuliryayo J. D., Vervaet C., Remon J. P., Eur. J. Pharm. Biopharm., 66, 460-465 (2007).
10. Xu J. C., Bovet L. L., Zhao K., Int. J. Pharm., 359, 63-69 (2008).
11. Laitinen R., Suihko E., Bjorkqvist M., Riikonen J., Lehto V. P., Jarvinen K., Ketolainen J., Drug Dev. Ind. Pharm., 36, 601-613 (2010).
12. Rahman Z., Zidan A. S., Khan M. A., Int. J. Pharm., 400, 49-58 (2010).
13. Sammour O. A., Hammad M. A., Megrab N. A., Zidan A. S., AAPS PharmSciTech, 7, 1-9 (2006).
14. Obaidat A. A., Obaidat R. M., Acta Pharm., 61, 83-91 (2011).
15. Szejtli J., Chem. Rev., 98, 1743-1754 (1998).
16. Bencini M., Ranucci E., Ferruti P., Trotta F., Donalisio M., Cornaglia M., Lembo D., Cavalli R., J. Controlled Release, 126, 17-25 (2008).
17. Snor W., Liedl E., Weiss-Greiler P., Viernstein H., Wolschann P., Int. J. Pharm., 381, 146-152 (2009).
18. Shah P. P., Mashru R. C., AAPS PharmSciTech, 9, 1025-1030 (2008).
19. Patel A. R., Vavia P. R., AAPS PharmSciTech, 9, 544-550 (2008).
20. Shivanand P., Devmurari V., Goyani M., Int. J. Pharm. Tech. Res., 2, 1639-1643 (2010).
21. Late S. G., Banga A. K., AAPS PharmSciTech, 11, 1627-1635 (2010).
22. Salústio P. J., Feio G., Figueirinhas J. L., Pinto J. F., Cabral Marques H. M., Eur. J. Pharm. Biopharm., 71, 377-386 (2009).
23. Aleem O., Kuchekar B., Pore Y., Late S., J. Pharm. Biomed. Anal., 47, 535-540 (2008).
24. Zhang J. Q., Liu J., Li X. L., Jasti B. R., Drug Deliv., 14, 381-387 (2007).
25. Liu J., Qiu L., Gao J., Jin Y., Int. J. Pharm., 312, 137-143 (2006).
26. Liu Y. M., Liu G. Y., Liu Y., Li S. J., Jia J. Y., Zhang M. Q., Lu C., Zhang Y. M., Li X. N., Yu C., Clin. Ther., 31, 1787-1795 (2009).
27. Tan Q. Y., Wang N., Yang H., Chen L., Xiong H. R., Zhang L. K., Liu J., Zhao C. J., Zhang J. Q., Drug Deliv., 17, 28-37 (2010).
28. Tan Q. Y., Xu M. L., Wu J. Y., Yin H. F., Zhang J. Q., Pharmazie, 67, 311-318 (2012).
29. Han L. M., Wang Z., Deng Y. J., Lin D. H., Chin. J. Pharm. Anal., 16, 396-397 (1996), in Chinese.
30. Tan Q. Y., Wang N., Yang H., Zhang L. K., Liu S., Chen L., Liu J., Zhang L., Hu N. N., Zhao C. J., Zhang J. Q., Int. J. Pharm., 384, 165-172 (2010).
31. Husain M. A., Roberts J. B., Thomas B. H., Wilson A., Br. J. Pharmacol, 34, 445-450 (1968).
32. Zhang J. Q., Zhang Z. R., Yang H., Tan Q. Y., Qin S. R., Qiu X. L., Pharm. Res., 22, 573-583 (2005).
33. Lu B., Zhang J. Q., Yang H., Drug Deliv., 10, 87-94 (2003).
34. Tan Q. Y., Hu N. N., Liu G. D., Yin H. F., Zhang L., Wang H., Lu L. Y., Zhang J. Q., Arch. Pharm. Res., 35, 499-508 (2012).
35. Jun S. W., Kim M. S., Kim J. S., Park H. J., Lee S., Woo J. S., Hwang S. J., Eur. J. Pharm. Biopharm., 66, 413-421 (2007).
36. Marques C. H., Hadgraft J., Kellaway I., Int. J. Pharm., 63, 259-266 (1990).
37. Watanabe Y., Koizumi K., Zama Y., Kiriyama M., Matsumoto Y., Matsumoto M., Biol. Pharm. Bull., 18, 1308-1310 (1995).
38. Ishikawa T., Mukai B., Shiraishi S., Utoguchi N., Fujii M., Matsumoto M., Watanabe Y., Chem. Pharm. Bull., 49, 134-139 (2001).